SCHEDULE: Major Israeli Financial Group Discloses Significant Stake in Pharmaceutical Giant

Menora Mivtachim Holdings Ltd. has disclosed a 5% beneficial ownership stake in Teva Pharmaceutical Industries Ltd., totaling 57,395,173 ordinary shares.

Summary

• Menora Mivtachim Holdings Ltd., an Israeli entity, has reported beneficial ownership of 57,395,173 Ordinary Shares of Teva Pharmaceutical Industries Ltd.
• This ownership represents 5% of the total Ordinary Shares outstanding, based on 1,146,838,689 shares as of July 17, 2025.
• The shares are primarily held by Menora Mivtachim's direct or indirect, wholly-owned or majority-owned subsidiaries, including Menora Mivtachim Pensions and Gemel Ltd. (49,906,622.76 shares or 4.35%), Menora Mivtachim Insurance Ltd. (7,027,829.89 shares or 0.61%), Menora Mivtachim Vehistadrut Hamehandesim Nihul Kupot Gemel Ltd. (355,268.35 shares or 0.03%), and Shomera Insurance Company Ltd. (105,452 shares or 0.01%).
• The reporting person holds shared voting and dispositive power over all 57,395,173 shares.
• The filing certifies that the securities were not acquired and are not held for the purpose or with the effect of changing or influencing the control of the issuer.

Sentiment

Score: 7

Explanation: The filing is a standard regulatory disclosure of a significant passive ownership stake, indicating a substantial investment by Menora Mivtachim Holdings Ltd. in Teva Pharmaceutical Industries Ltd. It does not contain performance-related information, but the transparency and size of the investment are positive from a market information perspective.

Positives

• The disclosure provides transparency regarding a significant passive investment in Teva Pharmaceutical Industries Ltd.
• The substantial investment by Menora Mivtachim Holdings Ltd. indicates a long-term, passive interest in the company.

Risks

• Menora Mivtachim Holdings Ltd. and its subsidiaries disclaim beneficial ownership of any securities except to the extent of their pecuniary interest therein, indicating a limitation on their direct financial exposure or control.

Future Outlook

The document is a beneficial ownership disclosure and does not contain forward-looking statements or guidance regarding the issuer's future performance or strategic outlook.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

This filing reflects a significant passive investment by a major Israeli financial and insurance group in Teva Pharmaceutical Industries Ltd., a global pharmaceutical company headquartered in Israel. Such investments are common for large institutional investors seeking diversified exposure within established industries.

Stakeholder Impact

• Shareholders: The disclosure of a significant passive investor provides transparency and may signal confidence in the company, potentially contributing to market stability.
• Employees, customers, suppliers, creditors: This ownership disclosure does not directly impact these stakeholders, as it pertains to a passive investment rather than operational or strategic changes.

Key Dates

Keywords

Teva Pharmaceutical Industries, Menora Mivtachim Holdings, Beneficial Ownership, SEC Filing, Schedule 13G, Ordinary Shares, Pharmaceuticals, Investment, Israel, Passive Stake